Amyloid beta a4 precursor protein-binding family b member 1 (fe65) interactomics revealed synaptic vesicle glycoprotein 2a (sv2a) and sarcoplasmic/endoplasmic reticulum calcium atpase 2 (serca2) as new binding proteins in the human brain

Molecular and Cellular Proteomics

Volumn 13, Issue 2, 2014, Pages 475-488

  Nensa, Fabian M ^a   Neumann, Martin H D ^a   Schrotter, Andreas ^a   Przyborski, Andre ^a   Mastalski, Thomas ^a   Susdalzew, Sergej ^a   Looe, Christina ^a   Helling, Stefan ^a   El Magraoui, Fouzi ^b   Erdmann, Ralf ^b   Meyer, Helmut E ^a,c   Uszkoreit, Julian ^a   Eisenacher, Martin ^a   Suh, Jaehong ^d   Guenette, Suzanne Y ^d   Ro Hner, Nelli ^e   Kogel, Donat ^e   Theiss, Carsten ^b   Marcus, Katrin ^a   Muller, Thorsten ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c LEIBNIZ INSTITUT FÜR ANALYTISCHE WISSENSCHAFTEN ISAS E V   (Germany)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA1 INTEGRIN; BINDING PROTEIN; PROTEOME; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ALZHEIMER DISEASE; ARTICLE; CALCIUM CELL LEVEL; HOMEOSTASIS; HUMAN; MASS SPECTROMETRY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEOMICS; SIGNAL TRANSDUCTION; SYNAPSE VESICLE;

ANIMALS; BRAIN; CELLS, CULTURED; EMBRYO, MAMMALIAN; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN INTERACTION MAPS; SYNAPSES;

EID: 84893318361     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.029280     Document Type: Article

References (71)

1. Ermekova, K. S., Zambrano, N., Linn, H., Minopoli, G., Gertler, F., Russo, T., and Sudol, M. (1997) The WW domain of neural protein FE65 interacts with proline-rich motifs in MENA, the mammalian homolog of Drosophila enabled. J. Biol. Chem. 272, 32869-32877
2. Espanel, X., and Sudol, M. (1999) A single point mutation in a group I WW domain shifts its specificity to that of group II WW domains. J. Biol. Chem. 274, 17284-17289
3. Borg, J. P., Ooi, J., Levy, E., and Margolis, B. (1996) The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol. Cell. Biol. 16, 6229-6241
4. Bressler, S. L., Gray, M. D., Sopher, B. L., Hu, Q., Hearn, M. G., Pham, D. G., Dinulos, M. B., Fukuchi, K., Sisodia, S. S., Miller, M. A., Disteche, C. M., and Martin, G. M. (1996) cDNA cloning and chromosome mapping of the human Fe65 gene: interaction of the conserved cytoplasmic domains of the human beta-amyloid precursor protein and its homologues with the mouse Fe65 protein. Hum. Mol. Genet. 5, 1589-1598
5. Selkoe, D. J. (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81, 741-766
6. Cao, X., and Sudhof, T. C. (2001) A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 115-120
7. Santiard-Baron, D., Langui, D., Delehedde, M., Delatour, B., Schombert, B., Touchet, N., Tremp, G., Paul, M. F., Blanchard, V., Sergeant, N., Delacourte, A., Duyckaerts, C., Pradier, L., and Mercken, L. (2005) Expression of human FE65 in amyloid precursor protein transgenic mice is associated with a reduction in beta-amyloid load. J. Neurochem. 93, 330-338
8. Pietrzik, C. U., Yoon, I. S., Jaeger, S., Busse, T., Weggen, S., and Koo, E. H. (2004) FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein. J. Neurosci. 24, 4259-4265
9. Kinoshita, A., Whelan, C. M., Berezovska, O., and Hyman, B. T. (2002) The gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein induces apoptosis via Tip60 in H4 cells. J. Biol. Chem. 277, 28530-28536
10. Ikin, A. F., Sabo, S. L., Lanier, L. M., and Buxbaum, J. D. (2007) A macromolecular complex involving the amyloid precursor protein (APP) and the cytosolic adapter FE65 is a negative regulator of axon branching. Mol. Cell. Neurosci. 35, 57-63
11. Sabo, S. L., Ikin, A. F., Buxbaum, J. D., and Greengard, P. (2001) The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement. J. Cell Biol. 153, 1403-1414
12. Sabo, S. L., Ikin, A. F., Buxbaum, J. D., and Greengard, P. (2003) The amyloid precursor protein and its regulatory protein, FE65, in growth cones and synapses in vitro and in vivo. J. Neurosci. 23, 5407-5415
13. Masin, M., Kerschensteiner, D., Dumke, K., Rubio, M. E., and Soto, F. (2006) Fe65 interacts with P2X2 subunits at excitatory synapses and modulates receptor function. J. Biol. Chem. 281, 4100-4108
14. Barbato, C., Canu, N., Zambrano, N., Serafino, A., Minopoli, G., Ciotti, M. T., Amadoro, G., Russo, T., and Calissano, P. (2005) Interaction of Tau with Fe65 links tau to APP. Neurobiol. Dis. 18, 399-408
15. Kinoshita, A., Whelan, C. M., Smith, C. J., Mikhailenko, I., Rebeck, G. W., Strickland, D. K., and Hyman, B. T. (2001) Demonstration by fluorescence resonance energy transfer of two sites of interaction between the low-density lipoprotein receptor-related protein and the amyloid precursor protein: role of the intracellular adapter protein Fe65. J. Neurosci. 21, 8354-8361
16. Hoe, H. S., Magill, L. A., Guenette, S., Fu, Z., Vicini, S., and Rebeck, G. W. (2006) FE65 interaction with the ApoE receptor ApoEr2. J. Biol. Chem. 281, 24521-24530
17. Dumanis, S. B., Chamberlain, K. A., Sohn, Y. J., Lee, Y. J., Guenette, S. Y., Suzuki, T., Mathews, P. M., Pak, D. T., Rebeck, G. W., Suh, Y. H., Park, H. S., and Hoe, H. S. (2012) FE65 as a link between VLDLR and APP to regulate their trafficking and processing. Mol. Neurodegener. 7, 9
18. Alvira-Botero, X., Perez-Gonzalez, R., Spuch, C., Vargas, T., Antequera, D., Garzon, M., Bermejo-Pareja, F., and Carro, E. (2010) Megalin interacts with APP and the intracellular adapter protein FE65 in neurons. Mol. Cell Neurosci. 45, 306-315
19. Bao, J., Cao, C., Zhang, X., Jiang, F., Nicosia, S. V., and Bai, W. (2007) Suppression of beta-amyloid precursor protein signaling into the nucleus by estrogens mediated through complex formation between the estrogen receptor and Fe65. Mol. Cell. Biol. 27, 1321-1333
20. Klug, W., Dietl, A., Simon, B., Sinning, I., and Wild, K. (2011) Phosphorylation of LRP1 regulates the interaction with Fe65. FEBS Lett. 585, 3229-3235
21. Mulvihill, M. M., Guttman, M., and Komives, E. A. (2011) Protein interactions among Fe65, the low-density lipoprotein receptor-related protein, and the amyloid precursor protein. Biochemistry 50, 6208-6216
22. Minopoli, G., de Candia, P., Bonetti, A., Faraonio, R., Zambrano, N., and Russo, T. (2001) The beta-amyloid precursor protein functions as a cytosolic anchoring site that prevents Fe65 nuclear translocation. J. Biol. Chem. 276, 6545-6550
23. Ando, K., Iijima, K. I., Elliott, J. I., Kirino, Y., and Suzuki, T. (2001) Phosphorylation- dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of beta-amyloid. J. Biol. Chem. 276, 40353-40361
24. Chang, K. A., Kim, H. S., Ha, T. Y., Ha, J. W., Shin, K. Y., Jeong, Y. H., Lee, J. P., Park, C. H., Kim, S., Baik, T. K., and Suh, Y. H. (2006) Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration. Mol. Cell. Biol. 26, 4327-4338
25. Radzimanowski, J., Simon, B., Sattler, M., Beyreuther, K., Sinning, I., and Wild, K. (2008) Structure of the intracellular domain of the amyloid precursor protein in complex with Fe65-PTB2. EMBO Rep. 9, 1134-1140
26. Radzimanowski, J., Ravaud, S., Schlesinger, S., Koch, J., Beyreuther, K., Sinning, I., and Wild, K. (2008) Crystal structure of the human Fe65-PTB1 domain. J. Biol. Chem. 283, 23113-23120
27. Zhou, D., Zambrano, N., Russo, T., and D'Adamio, L. (2009) Phosphorylation of a tyrosine in the amyloid-beta protein precursor intracellular domain inhibits Fe65 binding and signaling. J. Alzheimers Dis. 16, 301-307
28. Barbagallo, A. P., Weldon, R., Tamayev, R., Zhou, D., Giliberto, L., Foreman, O., and D'Adamio, L. (2010) Tyr(682) in the intracellular domain of APP regulates amyloidogenic APP processing in vivo. PLoS One 5, e15503
29. Lambert, J. C., Goumidi, L., Vrieze, F. W., Frigard, B., Harris, J. M., Cummings, A., Coates, J., Pasquier, F., Cottel, D., Gaillac, M., St, C. D., Mann, D. M., Hardy, J., Lendon, C. L., Amouyel, P., and Chartier-Harlin, M. C. (2000) The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. Hum. Mol. Genet. 9, 2275-2280
30. Zambrano, N., Minopoli, G., de Candia, P., and Russo, T. (1998) The Fe65 adaptor protein interacts through its PID1 domain with the transcription factor CP2/LSF/LBP1. J. Biol. Chem. 273, 20128-20133
31. Telese, F., Bruni, P., Donizetti, A., Gianni, D., D'Ambrosio, C., Scaloni, A., Zambrano, N., Rosenfeld, M. G., and Russo, T. (2005) Transcription regulation by the adaptor protein Fe65 and the nucleosome assembly factor SET. EMBO Rep. 6, 77-82
32. Kajiwara, Y., Akram, A., Katsel, P., Haroutunian, V., Schmeidler, J., Beecham, G., Haines, J. L., Pericak-Vance, M. A., and Buxbaum, J. D. (2009) FE65 binds Teashirt, inhibiting expression of the primate-specific caspase-4. PLoS One 4, e5071
33. Baek, S. H., Ohgi, K. A., Rose, D. W., Koo, E. H., Glass, C. K., and Rosenfeld, M. G. (2002) Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappa B and betaamyloid precursor protein. Cell 110, 55-67
34. Bimonte, M., Gianni, D., Allegra, D., Russo, T., and Zambrano, N. (2004) Mutation of the feh-1 gene, the Caenorhabditis elegans orthologue of mammalian Fe65, decreases the expression of two acetylcholinesterase genes. Eur. J. Neurosci. 20, 1483-1488
35. von Rotz, R. C., Kohli, B. M., Bosset, J., Meier, M., Suzuki, T., Nitsch, R. M., and Konietzko, U. (2004) The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J. Cell Sci. 117, 4435-4448
36. Muller, T., Concannon, C. G., Ward, M. W., Walsh, C. M., Tirniceriu, A. L., Tribl, F., Kogel, D., Prehn, J. H., and Egensperger, R. (2007) Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD). Mol. Biol. Cell 18, 201-210
37. Minopoli, G., Stante, M., Napolitano, F., Telese, F., Aloia, L., De, F. M., Di, L. R., Pacelli, R., Brunetti, A., Zambrano, N., and Russo, T. (2007) Essential roles for Fe65, Alzheimer amyloid precursor-binding protein, in the cellular response to DNA damage. J. Biol. Chem. 282, 831-835
38. Guenette, S., Chang, Y., Hiesberger, T., Richardson, J. A., Eckman, C. B., Eckman, E. A., Hammer, R. E., and Herz, J. (2006) Essential roles for the FE65 amyloid precursor protein-interacting proteins in brain development. EMBO J. 25, 420-431
39. Maerkens, A., Kley, R. A., Olive, M., Theis, V., van der Ven, P. F., Reimann, J., Milting, H., Schreiner, A., Uszkoreit, J., Eisenacher, M., Barkovits, K., Guttsches, A. K., Tonillo, J., Kuhlmann, K., Meyer, H. E., Schroder, R., Tegenthoff, M., Furst, D. O., Muller, T., Goldfarb, L. G., Vorgerd, M., and Marcus, K. (2013) Differential proteomic analysis of abnormal intramyoplasmic aggregates in desminopathy. J. Proteomics, 90, 14-27
40. Kley, R. A., Maerkens, A., Leber, Y., Theis, V., Schreiner, A., van der Ven, P. F., Uszkoreit, J., Stephan, C., Eulitz, S., Euler, N., Kirschner, J., Muller, K., Meyer, H. E., Tegenthoff, M., Furst, D. O., Vorgerd, M., Muller, T., and Marcus, K. (2013) A combined laser microdissection and mass spectrometry approach reveals new disease relevant proteins accumulating in aggregates of filaminopathy patients. Mol. Cell. Proteomics 12, 215-227
41. Schrotter, A., Pfeiffer, K., El, M. F., Platta, H., Erdmann, R., Meyer, H. E., Egensperger, R., Marcus, K., and Muller, T. (2012) The APP family members are key players in S-adenosylmethionine formation by MAT2A and modify BACE1 and PSEN1 gene expression - relevance for Alzheimer's disease. Mol. Cell. Proteomics 11, 1274-1288
42. Muller, T., Schrotter, A., Loosse, C., Pfeiffer, K., Theiss, C., Kauth, M., Meyer, H. E., and Marcus, K. (2013) A ternary complex consisting of AICD, FE65, and TIP60 down-regulates Stathmin1. Biochim. Biophys. Acta 1834, 387-394
43. Muller, T., Schrotter, A., Loosse, C., Helling, S., Stephan, C., Ahrens, M., Uszkoreit, J., Eisenacher, M., Meyer, H. E., and Marcus, K. (2011) Sense and nonsense of pathway analysis software in proteomics. J. Proteome Res. 10, 5398-5408
44. Muller, T., Loosse, C., Schrotter, A., Schnabel, A., Helling, S., Egensperger, R., and Marcus, K. (2011) The AICD interacting protein DAB1 is upregulated in Alzheimer frontal cortex brain samples and causes deregulation of proteins involved in gene expression changes. Curr. Alzheimer Res. 8, 573-582
45. Nowack, A., Malarkey, E. B., Yao, J., Bleckert, A., Hill, J., and Bajjalieh, S. M. (2011) Levetiracetam reverses synaptic deficits produced by overexpression of SV2A. PLoS One 6, e29560
46. Meller, K. (1992) Axoplasmic transport of horseradish peroxidase in single neurons of the dorsal root ganglion studied in vitro by microinjection. Cell Tissue Res. 270, 139-148
47. Spitzer, P., Klafki, H. W., Blennow, K., Buee, L., Esselmann, H., Herruka, S. K., Jimenez, C., Klivenyi, P., Lewczuk, P., Maler, J. M., Markus, K., Meyer, H. E., Morris, C., Muller, T., Otto, M., Parnetti, L., Soininen, H., Schraen, S., Teunissen, C., Vecsei, L., Zetterberg, H., and Wiltfang, J. (2010) cNEUPRO: novel biomarkers for neurodegenerative diseases. Int. J. Alzheimers Dis
48. Lee, E. J., Hyun, S., Chun, J., Shin, S. H., Lee, K. E., Yeon, K. H., Park, T. Y., and Kang, S. S. (2008) The PPLA motif of glycogen synthase kinase 3beta is required for interaction with Fe65. Mol. Cells 26, 100-105
49. Sumioka, A., Nagaishi, S., Yoshida, T., Lin, A., Miura, M., and Suzuki, T. (2005) Role of 14-3-3gamma in FE65-dependent gene transactivation mediated by the amyloid beta-protein precursor cytoplasmic fragment. J. Biol. Chem. 280, 42364-42374
50. Petrak, J., Ivanek, R., Toman, O., Cmejla, R., Cmejlova, J., Vyoral, D., Zivny, J., and Vulpe, C. D. (2008) Deja vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins. Proteomics 8, 1744-1749
51. Liu, X., Yu, X., Zack, D. J., Zhu, H., and Qian, J. (2008) TiGER: a database for tissue-specific gene expression and regulation. BMC Bioinformatics 9, 271
52. Yamaguchi, N., Xu, L., Pasek, D. A., Evans, K. E., Chen, S. R., and Meissner, G. (2005) Calmodulin regulation and identification of calmodulin binding region of type-3 ryanodine receptor calcium release channel. Biochemistry 44, 15074-15081
53. Schroetter, A., Mastalsik, T., Nensa, F. M., Neumann, M., Loosse, C., Pfeiffer, K., El Magraoui, F., Platta, H., Erdmann, R., Theiss, C., Uszkoreit, J., Eisenacher, M., Meyer, H. E., Marcus, K., and Mueller, T. (2013) FE65 regulates and interacts with the Bloom syndrome protein in dynamic nuclear spheres - potential relevance to Alzheimer's disease. J. Cell Sci. 126, 2480-2492
54. Arbabian, A., Brouland, J. P., Gelebart, P., Kovacs, T., Bobe, R., Enouf, J., and Papp, B. (2011) Endoplasmic reticulum calcium pumps and cancer. Biofactors 37, 139-149
55. Perez, C. F., Lopez, J. R., and Allen, P. D. (2005) Expression levels of RyR1 and RyR3 control resting free Ca2- in skeletal muscle. Am. J. Physiol. Cell Physiol. 288, C640-C649
56. Rishi, A. K., Yu, M., Tsai-Wu, J. J., Belani, C. P., Fontana, J. A., Baker, D. L., Periasamy, M., and Hussain, A. (1998) Gene amplification and transcriptional upregulation of the sarco/endoplasmic reticulum Ca2- transport ATPase in thapsigargin-resistant hamster smooth muscle cells. Nucleic Acids Res. 26, 4529-4537
57. Goodger, Z. V., Rajendran, L., Trutzel, A., Kohli, B. M., Nitsch, R. M., and Konietzko, U. (2009) Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway. J. Cell Sci. 122, 3703-3714
58. Ghosal, K., Vogt, D. L., Liang, M., Shen, Y., Lamb, B. T., and Pimplikar, S. W. (2009) Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain. Proc. Natl. Acad. Sci. U.S.A. 106, 18367-18372
59. Sabo, S. L., Lanier, L. M., Ikin, A. F., Khorkova, O., Sahasrabudhe, S., Greengard, P., and Buxbaum, J. D. (1999) Regulation of beta-amyloid secretion by FE65, an amyloid protein precursor-binding protein. J. Biol. Chem. 274, 7952-7957
60. Trommsdorff, M., Borg, J. P., Margolis, B., and Herz, J. (1998) Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J. Biol. Chem. 273, 33556-33560
61. Rogawski, M. A., and Bazil, C. W. (2008) New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K (v) 7/KCNQ/M potassium channels. Curr. Neurol. Neurosci. Rep. 8, 345-352
62. Palop, J. J., and Mucke, L. (2009) Epilepsy and cognitive impairments in Alzheimer disease. Arch. Neurol. 66, 435-440
63. Schallier, A., Smolders, I., Van, D. D., Loyens, E., De Deyn, P. P., Michotte, A., Michotte, Y., and Massie, A. (2011) Region- and age-specific changes in glutamate transport in the AbetaPP23 mouse model for Alzheimer's disease. J. Alzheimers Dis. 24, 287-300
64. Cassano, T., Serviddio, G., Gaetani, S., Romano, A., Dipasquale, P., Cianci, S., Bellanti, F., Laconca, L., Romano, A. D., Padalino, I., LaFerla, F. M., Nicoletti, F., Cuomo, V., and Vendemiale, G. (2012) Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease. Neurobiol. Aging 33, 1121
65. Wang, Y., Zhang, M., Moon, C., Hu, Q., Wang, B., Martin, G., Sun, Z., and Wang, H. (2009) The APP-interacting protein FE65 is required for hippocampus- dependent learning and long-term potentiation. Learn. Mem. 16, 537-544
66. Ho, A., Morishita, W., Atasoy, D., Liu, X., Tabuchi, K., Hammer, R. E., Malenka, R. C., and Sudhof, T. C. (2006) Genetic analysis of Mint/X11 proteins: essential presynaptic functions of a neuronal adaptor protein family. J. Neurosci. 26, 13089-13101
67. Bezprozvanny, I., and Mattson, M. P. (2008) Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci. 31, 454-463
68. Luo, D., Sun, H., Xiao, R. P., and Han, Q. (2005) Caffeine induced Ca2- release and capacitative Ca2- entry in human embryonic kidney (HEK293) cells. Eur. J. Pharmacol. 509, 109-115
69. Corona, C., Pensalfini, A., Frazzini, V., and Sensi, S. L. (2011) New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc. Cell Death Dis. 2, e176
70. Leissring, M. A., Murphy, M. P., Mead, T. R., Akbari, Y., Sugarman, M. C., Jannatipour, M., Anliker, B., Muller, U., Saftig, P., De Strooper, B., Wolfe, M. S., Golde, T. E., and LaFerla, F. M. (2002) A physiologic signaling role for the gamma-secretase-derived intracellular fragment of APP. Proc. Natl. Acad. Sci. U.S.A. 99, 4697-4702
71. Green, K. N., Demuro, A., Akbari, Y., Hitt, B. D., Smith, I. F., Parker, I., and LaFerla, F. M. (2008) SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production. J. Cell Biol. 181, 1107-1116